Association of renin-angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study.

Maria José SolerAida RiberaJosep R MarsalAna Belen MendezMireia AndresMaria Antonia AzancotGerard OristrellLeonardo Méndez-BooJordana CohenJose A BarrabésIgnacio Ferreira-Gonzáleznull null

Published in: Clinical kidney journal (2021)

RAS blockade in patients with HTN is not associated with higher risk of COVID-19 infection or with a worse progression of the disease.

Keyphrases

coronavirus disease
sars cov
blood pressure
angiotensin converting enzyme
wild type
respiratory syndrome coronavirus
angiotensin ii
arterial hypertension